Evidence map›Paper›PMID 25031350›Full record

ArticleJournal of virology2014

Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo.

Rui André Saraiva Raposo, Mohamed Abdel-Mohsen, Xutao Deng, Frederick M Hecht, Christopher D Pilcher, Satish K Pillai, Douglas F Nixon

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Antiviral gene expression in psoriasis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2015
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Rui André Saraiva RaposoDivision of Experimental Medicine, University of California San Francisco, San Francisco, California, USA Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, USA araposo@gwu.edu.
Mohamed Abdel-MohsenDepartment of Medicine, University of California San Francisco, San Francisco, California, USA Blood Systems Research Institute, San Francisco, California, USA.
Xutao DengBlood Systems Research Institute, San Francisco, California, USA.
Frederick M HechtUCSF Positive Health Program, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.
Christopher D PilcherUCSF Positive Health Program, San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.
Satish K PillaiBlood Systems Research Institute, San Francisco, California, USA Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Douglas F NixonDivision of Experimental Medicine, University of California San Francisco, San Francisco, California, USA Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, USA.
Blood Systems Research Institute · USGeorge Washington University · USSan Francisco General Hospital · USUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
The District of Columbia Developmental Center for AIDS Research (DC D-CFAR)P30AI087714 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI GREENBERG, ALAN EDWARD · 2010 to 2014
$8.4M
A novel APOBEC-based vaccine approach for HIVR33AI093179 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI NIXON, DOUGLAS F · 2014 to 2015
$1.5M
Antiviral Role of APOBEC3 in HIV/HCV Coinfected PatientsK01DA024654 · NIDA · VITALANT · PI PILLAI, SATISH KUMAR · 2008 to 2012
$902k
A novel APOBEC-based vaccine approach for HIVR21AI093179 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2011 to 2012
$456k
NIAID NIH HHS AI93179NIAID NIH HHS P30 AI027763NIAID NIH HHS P30-AI027763NIAID NIH HHS P30 AI087714NIAID NIH HHS P30AI087714NIAID NIH HHS R21 AI093179NIAID NIH HHS R33 AI093179NIDA NIH HHS 1K01DA024654NIDA NIH HHS K01 DA024654
6 · The paper itself

Abstract

In this study, we investigated the expression levels of host restriction factors in six untreated HIV-1-positive patients over the course of infection. We found that the host restriction factor gene expression profile consistently increased over time and was significantly associated with CD4+ T cell activation and viral load. Our data are among the first to demonstrate the dynamic nature of host restriction factors in vivo over time.

Indexed as

Gene Expression RegulationAdultCD4 Lymphocyte CountCD4-Positive T-LymphocytesGene Expression ProfilingHIV-1HIV InfectionsHost-Pathogen InteractionsHumansLongitudinal StudiesLymphocyte ActivationMaleRepressor ProteinsRNA, ViralViral LoadRepressor ProteinsRNA, Viral

Identifiers

PMID25031350
PMCPMC4178813
OpenAlexW2038850666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.